Product
Acamprosate
Aliases
Acamprosate(Campral)
6 clinical trials
4 indications
Indication
Alcohol Use DisorderIndication
Alcohol use disorderIndication
Essential TremorIndication
Liver TransplantClinical trial
Temporally-Resolved Electrophysiology of Acamprosate Treatment of Alcohol Use DisorderStatus: Not yet recruiting, Estimated PCD: 2025-12-31
Clinical trial
Pharmacogenomics and Pharmacometabolomics of Acamprosate Treatment OutcomeStatus: Completed, Estimated PCD: 2023-11-04
Clinical trial
Safety of Acamprosate for Alcohol Dependence in the Elderly: An Open-Label StudyStatus: Withdrawn, Estimated PCD: 2006-12-01
Clinical trial
Investigation of the Efficacy of Acamprosate and Calcium in Comparison to Placebo as Validation of a Behavioural Test for Alcohol Dependence (TEMACA)Status: Completed, Estimated PCD: 2023-08-30
Clinical trial
Acamprosate and Methazolamide for Essential Tremor: a Randomized Clinical TrialStatus: Withdrawn, Estimated PCD: 2017-06-01
Clinical trial
Safety of Acamprosate in Treating Alcohol Use Disorder in the Post Liver Transplant PopulationsStatus: Completed, Estimated PCD: 2023-07-30